Silica therapy to reduce the body burden of aluminium

There are unexplained links between human exposure to aluminium and the incidence, progression and aetiology of Alzheimer’s disease…. The reduction in urinary aluminium supported the future longer-term use of silicic acid as non-invasive therapy for reducing the body burden of aluminium in Alzheimer’s disease.

Abstract. Journal of Alzheimer’s disease : JAD 2006; 10(1):17-24; discussion 29-31